Skip to content

The study of fecal microbiota transplantation in improving gastrointestinal symptoms in children with autism spectrum disorder

The study of fecal microbiota transplantation in improving gastrointestinal symptoms in children with autism spectrum disorder

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055943
Enrollment
Unknown
Registered
2022-01-28
Start date
2022-01-28
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism spectrum disorder

Interventions

Fecal microbiota transplantation group:Fecal microbiota transplantation, routine rehabilitation and dietary intervention
Control group:Routine rehabilitation and dietary intervention

Sponsors

Shanghai Children’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 17 Years

Inclusion criteria

Inclusion criteria: 1. Aged 3 to 17 years; 2. Meet DSM-V criteria, the total score of CARS >= 30 points; 3. Autism Behavior Rating Scale (ABC) >= 67 points; 4. Complicated with gastrointestinal symptoms; 5. The legal guardian fully understood and signed the informed consent, agreeing to collect clinical data and peripheral blood and stool samples; 6. Continued participation in the project and follow-up for 6 months.

Exclusion criteria

Exclusion criteria: 1. Rett syndrome was definitely diagnosed; 2. With other serious systemic diseases and a clear history of organic brain diseases such as brain trauma, cerebral palsy and encephalitis; 3. Those who have been explicitly diagnosed with other mental diseases; 4. Use of probiotics, antibiotics, acid suppressors and other drugs affecting intestinal microbiota in the last 3 months; 5. Complicated with other serious gastrointestinal diseases, intestinal organic lesions such as congenital megacolon, intestinal obstruction, intussusception, etc.; 6. Poor compliance.

Design outcomes

Primary

MeasureTime frame
The mean GSRS score of the subjects decreased by > 50% after treatment;The incidence of free and hard stools (type 1 or 2) and soft and liquid stools (type 6 or 7) decreased after treatment;

Secondary

MeasureTime frame
The scores of the Childhood Autism Rating Scale (CARS), the Autism Behavior Rating Scale (ABC) and the Social Response Scale (SRS) decreased;

Countries

China

Contacts

Public ContactZhang Ting

Shanghai Children’s Hospital

zhangt@shchildren.com.cn+86 180 1648 7615

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026